Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Four Generic Products (global rights)

M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Portfolio of global rights related to four generic pharmaceuticals. The products include sodium feredetate oral solution for the treatment of anemia, trazadone oral solution for the treatment of depression and two additional pipeline products.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Acquirer
Primary Office
  • United States

Four Generic Products (global rights) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Four Generic Products (global rights)‘s full profile, request access.

Request full access to PitchBook